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Background: Patients with myocardial bridging (MB) are associated with adverse 
cardiovascular events, but a decision to perform surgical intervention, especially for 
patients with systolic intermediate stenosis, is a difficult clinical issue. Fractional flow 
reserve (FFR) represents a novel method for the functional evaluation of coronary 
stenosis, but the relationship between FFR and MB remains controversial because of 
the cyclic dynamic stenosis of MB. Quantitative flow ratio (QFR) is a novel index 
allowing fast assessment of FFR from a diagnostic coronary angiography. This study 
aimed to investigate the relationship between QFR and MB patients and to further 
develop a prediction model of QFR-guided surgical intervention for these patients. 
Methods: Forty-five symptomatic lone MB patients who had undergone coronary 
angiography were consecutively enrolled in this study. MB was located in the middle 
of left anterior descending artery with intermediate stenosis during systole. The 
patients were retrospectively divided into a medical therapy group or a surgical 
therapy group. Systolic geometry based QFR (SG-QFR) and diastolic geometry based 
QFR (DG-QFR) were calculated based on three-dimensional quantitative coronary 
angiography (QCA) and patient-specific flow velocity. Subsequently, time-averaged 
QFR (TA-QFR) is defined as the average of SG-QFR and DG-QFR.  
Results: Receiver operating characteristic curve analysis revealed that TA-QFR was 
found to be the best pre-operative index for surgical intervention to MB, when 
compared with DG-QFR and SG-QFR.  
Conclusions: TA-QFR improved the performance of functional evaluation in MB 
patients with intermediate stenosis during systole and is useful for guiding surgical 
intervention.  




Myocardial bridging (MB) is a band of myocardial tissue, under which a 
segment of the coronary artery running in the epicardial tissue. The characteristic 
angiographic appearance of MB shows systolic narrowing of the artery with relatively 
normal vessel diameter during diastole. MB has once been considered as a benign 
condition. However, recent studies have suggested that MB was associated with 
myocardial ischemia, atrialventricular block, arrhythmias, and even sudden cardiac 
death [1–3]. Therefore, an effective assessment model is desirable for clinical 
decision making in patients with MB, especially when coupled with intermediate 
stenosis during systole.  
The concept of the fractional flow reserve (FFR) was developed by Pijls in 
1995 [4]. The measurement of FFR is increasingly used to evaluate the functional 
significance of coronary stenosis and it was demonstrated to be a good performance 
[5]. However, because of potential limitations of conventional FFR, like 
time-consuming, high expense, and other factors, utilization of FFR world-wide make 
it a poor choice, in general, with a few exceptions [6]. Quantitative flow ratio (QFR) 
is a novel index allowing a quick assessment of FFR from a diagnostic coronary 
angiography, which has the potential to resolve the limitations of FFR, as mentioned 
above [7–9]. Due to the cyclical, dynamic nature of stenosis in MB patients (dynamic 
compression of the coronary artery extending from the systole into the diastole), using 
the conventional QFR computation is not adequate in evaluating MB [10]. On the 
other hand, QFR can be computed from specific stenotic geometry during cardiac 
cycle. The objective of this study was to demonstrate that a combination of QFR 
computations at different cardiac phases could be used to predict patients with MB 




This was a retrospective and observational study. Symptomatic lone MB 
patients who had undergone coronary angiography were included. All patients were 
given optimal doses of beta-blockers (BB) and calcium channel blockers (CCB). 
During follow-up, if medical therapy was not adequate to relieve symptoms of 
patients with MB, then coronary artery bypass grafting or surgical myotomy was 
performed. The other patients were continued on medical therapy. So, the patients 
were divided into two groups: the medical therapy group or the surgical therapy group. 
An overview of the study design is demonstrated in Figure 1. It was hypothesized that 
a combination of QFR computations at different cardiac phases can be used to predict 
patients with MB who require surgical intervention. The study protocol was approved 
by the ethics committee of the documented hospital. 
 
Study population  
A total of 45 symptomatic lone MB patients who underwent invasive 
coronary angiography at Ruijin Hospital, Shanghai Jiao Tong University School of 
Medicine, Shanghai, China, from September 2016 to January 2019, were 
consecutively enrolled in this study. Inclusion criteria were: 1) age >18 years; 2) all 
patients were diagnosed with MB in a catheterization laboratory. The characteristic 
angiographic appearance of MB includes systolic narrowing or the so called “milking 
effect” of the artery with a relatively normal vessel diameter during the diastolic 
period; 3) MB patients who were identified as having systolic stenosis in mid-left 
anterior descending coronary artery segment; 4) the MB in all patients had 
intermediate stenosis during systole (defined by a percent diameter stenosis 30% to 
75% during systole by visual estimation); 5) all patients were given optimal doses of 
BB and CCB with the objective of relieving symptoms and signs of myocardial 
ischemia; 6) two angiographic projections > 25° apart were recorded by flat-panel 
X-ray systems; 7) nitroglycerine was given prior to the angiographic acquisitions. 
Exclusion criteria were: 1) overlap or foreshortening (> 90%) between nearby vessels 
in ICA images; 2) poor ICA image quality.  
 
Invasive coronary angiography image acquisition, geometrical reconstruction and 
QFR computation  
Angiographic images were recorded at 15 frames/s by monoplane X-ray 
systems (Innova 2100, GE). ICA images were analyzed by an experienced analyst 
who had been trained in three-dimensional quantitative coronary angiography (3D 
QCA) and QFR. Angiographic projections with minimal overlap and foreshortening 
were selected, then 3D geometrical reconstruction was performed and QFR was 
computed, using a prototype software package (QAngio XA 3D prototype, Medis 
special bv, Leiden, the Netherlands) [8]. Angiographic views at end-systolic and 
end-diastolic phases were selected and the interrogated vessel was reconstructed at 
both end-systolic and end-diastolic phases. Subsequently, the systolic geometry based 
QFR (SG-QFR) and diastolic geometry based QFR (DG-QFR) were derived using 
patient-specific flow velocity and a recently developed QFR computational algorithm 
[8, 11]. Vessel QFR at the most distal position of the reconstructed vessel was used. 




Normally distributed continuous variables are expressed as mean ± standard 
deviation or as median if abnormally distributed, whereas categorical variables are 
expressed as percentages. Clinical characteristics data were collected per-patient and 
remaining calculations were on a per-vessel basis. The performance of TA-QFR, 
SG-QFR and DG-QFR in predicting lesions was assessed by using accuracy, 
sensitivity, specificity, positive predictive value (PPV), negative predictive value 
(NPV) together with their 95% confidence intervals (CIs), then by making a 
comparison between prognostic performance of TA-QFR, SG-QFR and DG-QFR. 
Receiver-operating characteristic (ROC) curves were generated and the area under the 
curve was calculated. The Youden index was used as a criterion to identify the 
optimal cutoff value for TA-QFR, SG-QFR and DG-QFR in predicting surgical 
intervention. Paired comparisons in ROC curves were performed by the DeLong 
method using MedCalc (version 13.0, MedCalc Software BVBA, Ostend, Belgium). 
Comparisons between the two groups were performed using the Student t-test with 
IBM SPSS (version 19.0, Armonk, New York). p < 0.05 was considered to be 
statistically significant.  
 
Results 
Patient baseline clinical and stenosis characteristics 
A total of 45 symptomatic MB patients with intermediate stenosis during 
systole were consecutively included. Twenty (44.4%) patients remained symptomatic 
despite optimal doses of BB or CCB. No major cardiac events were observed and all 
patients were asymptomatic during follow-up in both groups. Patient baseline clinical 
characteristics are listed in Table 1. There were no statistically significant differences 
between the two groups regarding patient clinical characteristics. Stenosis 
characteristics are listed in Table 2. At the end-diastolic phase, interrogated vessels 
had an average percent diameter stenosis (DS%), minimum lumen diameter (MLD), 
reference vessel diameter and minimum lumen area (MLA) of 26.1 ± 6.7% vs. 33.2 ± 
11.5% (p = 0.02), 1.57 ± 0.29 mm vs. 1.55 ± 0.29 mm (p = 0.80), 2.20 ± 0.40 mm vs. 
2.36 ± 0.27 mm (p = 0.12), 2.07 ± 0.81 mm2 vs. 2.22 ± 0.79 mm2 (p = 0.52) for the 
medical therapy group compared with the surgical therapy group whereas at the 
end-systolic phase, the same vessels interrogated had an average DS%, MLD, 
reference vessel diameter and MLA of 41.4 ± 9.1% vs. 57.3 ± 9.5% (p = 0.00), 1.29 ± 
0.30 mm vs. 1.02 ± 0.19 mm (p = 0.00), 2.20 ± 0.40 mm vs. 2.41 ± 0.29 mm (p = 
0.05), 1.52 ± 0.61 mm2 vs. 1.13 ± 0.40 mm2 (p = 0.02) during systole between two 
groups, respectively. Representative examples of X-ray angiography, 3D 
angiographic reconstruction and computation of QFR are shown in Figures 2 and 3. 
 
Computation of QFR 
The computed QFR values are listed in Table 3. DG-QFR between the two 
groups was 0.96 ± 0.02 vs. 0.93 ± 0.06 (p = 0.03) and SG-QFR between the two 
groups was 0.89 ± 0.07 vs. 0.74 ± 0.10 (p = 0.00). TA-QFR between the two groups 
was 0.92 ± 0.03 vs. 0.83 ± 0.06 (p = 0.00). 
 
Accuracy of TA-QFR for diagnostic performance 
TA-QFR had a greater area under the curve (AUC = 0.91; 95% confidence 
interval [CI] 0.79–0.98), when compared with DG-QFR (AUC = 0.69; 95% CI 
0.53–0.82]; difference: 0.22; 95% CI 0.04–0.41; p = 0.02) and SG-QFR (AUC = 0.87; 
95% CI 0.74–0.95; difference: 0.04; 95% CI 0.00–0.08; p = 0.03) (Fig. 4). From the 
ROC curve, the best cutoff value for TA-QFR in predicting patients requiring surgical 
therapy was found at 0.88. This resulted in a better diagnostic performance, with an 
accuracy of 89%, sensitivity of 85%, specificity of 92%, PPV of 90% and NPV of 
89%. Applying a cutoff value of 0.88 to TA-QFR resulted in 23 true positives, 17 true 
negatives, 2 false positives, and 3 false negatives. The diagnostic performance of 
TA-QFR versus DG-QFR, and SG-QFR was listed in Table 4. 
 
Discussion 
The main findings of the present study are: 1) TA-QFR is a novel index to 
assess patients with MB; 2) TA-QFR has a higher value in predicting MB patients 
who require surgical intervention, when compared with DG-QFR and SG-QFR; 3) 
The optimal cut-off value of TA-QFR in predicting MB patients who require surgical 
intervention was 0.88, with an overall accuracy of 89%, sensitivity of 85%, specificity 
of 92%, PPV of 90% and NPV of 89%, respectively. 
Myocardial bridging is a congenital coronary anomaly, and the incidence of 
MB is highest in the left anterior descending coronary artery [12]. MB appears as 
systolic compression by invasive coronary with relatively normal vessel diameter 
during diastole. It has been acknowledged that MB can influence dynamic nature of 
coronary arteries. Furthermore, some studies showed that myocardial vessel 
compression existed not only in systole but was also persistent during diastole [13]. In 
some studies, and case reports, it was associated with cardiac ischemia, angina, 
arrhythmias, or even sudden death [14, 15]. However, the optimal approach to assess 
MB by coronary angiography as well as by FFR remains unclear, due to the cyclic 
dynamic stenosis of MB [16]. Therefore, MB often causes clinical dilemmas, which 
widely raise concerns [17]. 
Fractional flow reserve has been recommended as class IA evidence for 
identifying hemodynamically significant coronary lesions when evidence of 
myocardial ischemia is unavailable according to the European Society of Cardiology 
guidelines and is increasingly applied in clinical settings for the time being [18, 19]. 
However, the adoption of conventional FFR is limited due to aforementioned practical 
drawbacks. QFR emerges as a novel, fast, non-invasive method for the assessment of 
FFR, which based on patient-specific flow velocity and a coronary geometric model, 
shows good correlation and agreement with pressure-derived FFR, with a diagnostic 
accuracy of 86% (95% CI 78% to 93%) [8, 20]. 
Fractional flow reserve assessment of MB has caused longstanding concerns. 
It has been reported that diagnostic functional severity of MB was facilitated after 
inotropic stimulation, which can increase vessel compression in MB [21]. Escaned 
demonstrated that a combination of diastolic FFR with dobutamine being chosen as an 
inotropic challenge among patients with MB, improved the assessment of myocardial 
ischemia. However, the significance of dobutamine testing for clinical 
decision-making remained unclear and the acquisition of diastolic FFR was a 
sophisticated procedure with measuring errors [10, 22]. Moreover, limited application 
of conventional FFR was found among patients with MB, as time-consuming, side 
effects associated with vasodilator administration, higher expense, etc. Conventional 
FFR is inadequate for MB assessment since cyclic dynamic stenosis during cardiac 
cycle, results in an underestimation of functional stenosis severity of MB [10, 23]. 
Therefore, a reasonable FFR-guided assessment model is demanded for guiding 
therapeutic strategies of patients with symptomatic lone MB. 
In the present study, SG-QFR, DG-QFR was calculated for each patient and 
geometric models were reconstructed at the end-systolic phase and at the end-diastolic 
phase, respectively. As the existence of cyclic dynamic stenosis, that is, systolic 
compression and diastolic are relatively normal, hemodynamic significance might be 
overestimated or underestimated in the systolic phase or diastolic phase. FFR 
measurement during the diastolic phase seems inadequate for MB assessment [10]. 
However, QFR computation was not done during the whole systolic phase nor the 
diastolic phase. Thus, computational deviation cannot be neglected. TA-QFR, unlike 
conventional FFR which is measured during the whole cardiac cycle, and is defined as 
the average of SG-QFR and DG-QFR, can both consider the systolic phase and the 
diastolic phase and then compensate for the downsides of SG-QFR, DG-QFR. As 
shown in Figure 4, AUC was significantly higher for TA-QFR (AUC = 0.91; 95% CI 
0.79–0.98) compared with DG-QFR (AUC = 0.69; 95% CI 0.53–0.82) and SG-QFR 
(AUC = 0.87; 95% CI 0.74–0.95]. So TA-QFR can improve the performance of a 
functional evaluation in MB patients with intermediate stenosis during systole, with 
an accuracy of 89% (SG-QFR ≤ 0.88) and shows the superiority of TA-QFR over 
other conventional methods for the assessment of patients with MB who require 
surgical intervention with an optimal cut-off value of 0.88. 
 
Conclusions 
The time-averaged QFR improved the performance of functional evaluation 
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 Table 1.  Patient baseline clinical characteristics (n = 45). 
Risk factors Medical therapy group 
(n = 25) 
Surgical therapy group 
(n = 20) 
P 
Age [years] 59.16 ± 9.67 55.80 ± 7.61 0.21 
Female, sex 14 (25%) 6 (20%) 0.08 
Body mass index [kg/m2] 23.35 ± 3.70 24.59 ± 2.87 0.22 
History of blood pressure 5 (24%) 3 (21%) 0.86 
Diabetes 3 (24%) 5 (21%) 0.55 
Hypercholesteremia 3 (24%) 3 (21%)  1.00 
Smoking 7 (24%) 5 (21%) 0.69 
EuroSCORE 0.64 ± 0.12 0.62 ± 0.16 0.58 
Percent of medical therapy:    
Beta-blocker 18 (25%) 14 (20%) 0.88 
        Dose/day [mg] 36.94 ± 12.14 33.93 ± 12.20 0.49 
    CCB 7 (25%) 6 (20%) 0.88 
Dose/day [mg] 62.50 ± 22.57 67.50 ± 23.35 0.55 
Time (follow-up) [months] 22.76 ± 10.30 23.15 ± 8.53 0.89 
Variables are in number (%), mean ± standard deviation; CCB — calcium channel blocker 
 
Table 2. Baseline lesion characteristics (n = 45). 
 Diastole  Systole  
Baseline lesion characteristics Medical therapy group Surgical therapy group P Medical therapy group Surgical therapy group P 
Percent diameter stenosis 26.1 ± 6.7 33.2 ± 11.5 0.02 41.4 ± 9.1 57.3 ± 9.5 0.00 
Minimum lumen diameter [mm] 1.57 ± 0.29 1.55 ± 0.29 0.80 1.29 ± 0.30 1.02 ± 0.19 0.00 
Reference vessel diameter [mm] 2.20 ± 0.40 2.36 ± 0.27 0.12 2.20 ± 0.40 2.41 ± 0.29 0.06 
Minimum lumen area [mm
2
] 2.07 ± 0.81 2.22 ± 0.79 0.52 1.52 ± 0.61 1.13 ± 0.40 0.02 
Variables are mean ± standard deviation. Anatomical parameters were quantified by 3-dimensional 
quantitative coronary. 
 
Table 3. Quantitative flow ratio (QFR) between the two groups (n = 45).  
QFR Medical therapy group Surgical therapy group P 
DG-QFR 0.96 ± 0.02 0.93 ± 0.06 0.03 
SG-QFR 0.89 ± 0.07 0.74 ± 0.10 0.00 
TA-QFR 0.92 ± 0.03 0.83 ± 0.06 0.00 
Variables are mean ± standard deviation. SG-QFR — systolic geometry based QFR; DG-QFR 
— diastolic geometry based QFR; TA-QFR — time-averaged QFR 
 
 
Table 4. Diagnostic performance of quantitative flow ratio (QFR) and 
three-dimensional quantitative coronary angiography anatomical indices. 
 TA-QFR ≤ 0.88 DG-QFR ≤ 0.93 SG-QFR ≤ 0.78 
Accuracy 89 (80–98) 71 (58–84) 84 (73–96) 
Sensitivity 85 (62–97) 50 (27–73) 75 (51–91) 
Specificity 92 (74–99) 88 (69–98) 92 (74–99) 
PPV 90 (66–99) 77 (46–95) 88 (63–99) 
NPV 89 (70–98) 69 (50–84) 82 (63–94) 
Values are number (95% confidence interval). SG-QFR—  systolic geometry based QFR; 
DG-QFR — diastolic geometry based QFR; TA-QFR — time-averaged QFR; PPV — positive 
predictive value; NPV — negative predictive value 
 
 
Figure 1. Overview of the study design; MB — myocardial bridging; SG-QFR — 
systolic geometry based quantitative flow ratio; DG-QFR — diastolic geometry based 
quantitative flow ratio; TA-QFR — time-averaged quantitative flow ratio. 
 
Figure 2. Three-dimensional angiographic reconstruction and computation of 
quantitative flow ratio (QFR) in the surgical therapy group; A1a, A1b. X-ray 
angiographic projectionsat end-diastolic phase; B1a, B1b. X-ray angiographic 
projectionsat end-systolic phase; A2. Diastolic geometry reconstructed from panel 1a 
and panel 1b; B2. Systolic geometry reconstructed from panel B1a and panel B1b; A3. 
DG-QFR computed from the diastolic geometry; B3. SG-QFR computed from the 
systolic geometry.  
 
Figure 3. Three dimensional angiographic reconstruction and computation of 
quantitative flow ratio (QFR) in the medical therapy group; A1a, A1b. X-ray 
angiographic projectionsat end-diastolic phase; B1a, B1b. X-ray angiographic 
projectionsat end-systolic phase; A2. Diastolic geometry reconstructed from panel 1a 
and panel 1b; B2. Systolic geometry reconstructed from panel B1a and panel B1b; A3. 
DG-QFR computed from the diastolic geometry; B3. SG-QFR computed from the 
systolic geometry.  
 
Figure 4. Receiver operating characteristic (ROC) curves for the discrimination of 
functionally significant stenosis. ROC curves compare sensitivity and specificity of 
TA-QFR versus DG-QFR (p = 0.02) and SG-QFR (p = 0.03) for the prediction of 
surgical intervention for myocardial bridging patients; SG-QFR — systolic geometry 
based quantitative flow ratio; DG-QFR — diastolic geometry based quantitative flow 
ratio; TA-QFR — time-averaged quantitative flow ratio. 
 
 




